NORMOGONADOTROP TUXUMOLON ETMASHMAYLIGIDA POLIKISTIK TUXUMOLON SINDROMINING TARQASHI

Tojieva Iroda Mirsoli qizi
Nashr sanasi https://doi.org/10.56121/2181-3612-2025-2-14-17
TO'LIQ MATN:

Abstrakt

Tadqiqot maqsadi: Normogonadotropik tuxumdonlar etishmovchiligida PCOS tarqalishini tashxislash va baholash. Materiallar va usullar.Ushbu retrospektiv tadqiqot 2019-yil yanvaridan 2023-yil iyunigacha Respublika ixtisoslashtirilgan ilmiy-amaliy endokrinologiya tibbiyot markaziga murojaat qilgan reproduktiv yoshdagi bemorlarning ma’lumotlar bazasi asosida olib borildi. Tadqiqot reproduktiv yoshdagi ayollarning sog‘lig‘ining turli jihatlarini va ularning reproduktiv tizimini o‘rganishga qaratilgan. Natijalar.2019-yil yanvaridan 2023-yil iyunigacha Respublika ixtisoslashtirilgan ilmiy-amaliy endokrinologiya tibbiyot markazining konsultativ poliklinikasiga 56 977 reproduktiv yoshdagi ayol murojaat qilgan. Ulardan 4 786 nafari FSG (follikulostimulyatsion gormon) va 4 372 nafari LG (lyuteinizatsion gormon) darajasi baholangan. 3 916 (81,8%) ayolda gonadotrop gormonlar darajasi normal diapazonda bo‘lgan. Ularning 572 nafari hayz siklining buzilishi haqida shikoyat qilgan. 66% ayollarga 2018-yilgi Rotterdam mezonlariga muvofiq PTOS tashxisi qo‘yilgan. Xulosa.Ushbu tadqiqotda biz normogonadotrop tuxumdon yetishmovchiligi bo‘lgan ayollar orasida PTOSning tarqalishini baholadik (JST bo‘yicha 2-sinf anovulyatsiyasi). Ushbu guruhdagi bemorlarning 66%ida PTOS aniqlandi.

Mualliflar haqida

Tojieva Iroda Mirsoli qizi
E.X.To‘raqulov nomidagi Respublika ixtisoslashtirilgan endokrinologiya ilmiy-amaliy tibbiyot markazi

Adabiyotlar ro'yxati

Abashova, Elena I., Maria A. Shalina, Elena V. Misharina, Natalia N. Tkachenko and Olga L. Bulgakova. “Clinical features of polycystic ovary syndrome phenotypes in women with normogonadotropic anovulation in reproductive age.” Journal of obstetrics and women's diseases 2019 68 (3):7-14. doi:10.17816/JOWD6837-14

Berga SL. Brain phenotype in PCOS: androgens, anovulation, and gender. Gynecol Endocrinol. 2022 Aug;38(8):615-616. doi: 10.1080/09513590.2022.2106475. PMID: 35971943.

Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG. 2006 Oct;113(10):1210-7. doi: 10.1111/j.1471-0528.2006.01008.x. PMID: 16972863

Dejager S, Pichard C, Giral P, et al. Smaller LDL particle size in women with polycystic ovary syndrome compared to controls. Clin Endocrinol. 2001;54:455–462

Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F, Sancho J, San Millán JL. The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab. 2005 Dec;90(12):6364-9. doi: 10.1210/jc.2005-1490. Epub 2005 Sep 27. PMID: 16189250

Talbott E, Clerici A, Berga SL, et al. Adverse lipid and coronary heart risk profiles in young women with polycystic ovary syndrome:results of a case-control study. J Clin Epidemiol. 1998;51:415–422

Teede H. J., Misso M. L., Costello M. F., Dokras A., Laven J., Moran L. et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome // Clin Endocrinol. 2018; 89 (3): 251–268. DOI: org/10.1111/cen13795

Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020 Mar;502:214-221. doi: 10.1016/j.cca.2019.11.003. Epub 2019 Nov 13. PMID: 31733195.

How to Cite

1.
Tojieva I. NORMOGONADOTROP TUXUMOLON ETMASHMAYLIGIDA POLIKISTIK TUXUMOLON SINDROMINING TARQASHI. MSU [Internet]. 2025 Apr. 16 [cited 2025 Apr. 20];(2):14-7. Available from: https://fdoctors.uz/index.php/journal/article/view/106
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Ko'rishlar soni: 3